文献速递肿瘤 PET/CT

动态全身18F-FDG PET鉴别异常病灶与生理性摄取

Dynamic whole-body 18F-FDG PET for differentiating abnormal lesions from physiological uptake.
PubMed 文献 · Eur J Nucl Med Mol Imaging · 2020-03-18

研究对88例疑似癌症患者行4次3分钟动态全身18F-FDG PET显像,由两名核医学医师依据摄取形态随时间变化将高摄取区分为「变化」或「不变」。86个良恶性病灶中84个(98%)为「不变」,该标准鉴别病理摄取的灵敏度97%、特异度76%、PPV 70%、NPV 98%、准确率84%。

要点

  • 动态全身18F-FDG PET图像质量满足视觉评估需要。
  • 生理性高摄取区118/154(77%)随时间呈「变化」。
  • 病灶中84/86(98%)随时间呈「不变」。

核心结论

  • 基于摄取形态视觉变化的动态全身18F-FDG PET可鉴别泌尿道和胃肠道病理性摄取与生理性摄取。

研究设计与样本

  • 在88例疑似癌症患者中,自18F-FDG给药后60分钟起行4次3分钟动态全身PET显像。
  • 由两名核医学医师依据摄取形态随时间变化将高18F-FDG摄取区分为「变化」或「不变」,并与常规图像评估比较。

主要发现

  • 动态图像评估在154个生理性高摄取区中118个(77%)为「变化」:胃9/19(47%)、小肠32/39(82%)、结肠17/33(52%)、泌尿道60/63(95%)。
  • 86个良性或恶性病灶中84个(98%)为「不变」。
  • 以「不变」判定病理性摄取的灵敏度97%、特异度76%、PPV 70%、NPV 98%、准确率84%。

关键数值与推荐

  • 高18F-FDG摄取区若随时间无变化,则高度可能为病理性摄取,灵敏度97%、特异度76%、PPV 70%、NPV 98%、准确率84%。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Serial assessment of visual change in 18F-FDG uptake on whole-body 18F-FDG PET imaging was performed to differentiate pathological uptake from physiological uptake in the urinary and gastrointestinal tracts. METHODS: In 88 suspected cancer patients, serial 3-min dynamic whole-body PET imaging was performed four times, from 60 min after 18F-FDG administration. In dynamic image evaluation, high 18F-FDG uptake was evaluated by two nuclear medicine physicians and classified as "changed" or "unchanged" based on change in uptake shape over time. Detectability of pathological uptake based on these criteria was assessed and compared with conventional image evaluation. RESULTS: Dynamic whole-body PET imaging provided images of adequate quality for visual assessment. Dynamic image evaluation was "changed" in 118/154 regions of high physiological 18F-FDG uptake (77%): in 9/19 areas in the stomach (47%), in 32/39 in the small intestine (82%), in 17/33 in the colon (52%), and in 60/63 in the urinary tract (95%). In the 86 benign or malignant lesions, 84 lesions (98%) were "unchanged." A high 18F-FDG uptake area that shows no change over time using these criteria is highly likely to represent pathological uptake, with sensitivity of 97%, specificity of 76%, PPV of 70%, NPV of 98%, and accuracy of 84%. CONCLUSION: Dynamic whole-body 18F-FDG PET imaging enabled differentiation of pathological uptake from physiological uptake in the urinary and gastrointestinal tracts, based on visual change of uptake shape.

来源:Eur J Nucl Med Mol Imaging,查看原文。版权归原作者所有。

引用

  1. Nishimura M, Tamaki N, Matsushima S, et al. Dynamic whole-body 18F-FDG PET for differentiating abnormal lesions from physiological uptake. Eur J Nucl Med Mol Imaging. 2020. PMID: 32189027. doi:10.1007/s00259-020-04726-w

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。